[Federal Register Volume 75, Number 161 (Friday, August 20, 2010)]
[Notices]
[Pages 51466-51467]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-20675]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Scientific Management Review Board.
    The NIH Reform Act of 2006 (Pub. L. 109-482) provides 
organizational authorities to HHS and NIH officials to: (1) Establish 
or abolish national research institutes; (2) reorganize the offices 
within the Office of the Director, NIH including adding, removing, or 
transferring the functions of such offices

[[Page 51467]]

or establishing or terminating such offices; and (3) reorganize, 
divisions, centers, or other administrative units within an NIH 
national research institute or national center including adding, 
removing, or transferring the functions of such units, or establishing 
or terminating such units. The purpose of the Scientific Management 
Review Board (also referred to as SMRB or Board) is to advise 
appropriate HHS and NIH officials on the use of these organizational 
authorities and identify the reasons underlying the recommendations.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Scientific Management Review Board.
    Date: September 14-15, 2010.
    Time: September 14, 2010, 8:30 a.m. to 5:30 p.m.
    Agenda: The focus of this meeting will be on the deliberations 
of the Translational Medicine and Therapeutics working group and its 
respective stakeholder consultation. Presentation and discussion 
will include, but is not limited to, representatives from academia, 
government, industry, venture capital firms, and patient advocacy 
groups. Additional presentation and discussion will include 
recommendations from the Substance Use, Abuse and Addiction working 
group and the Intramural Research Program working group. Time will 
be allotted both days for presentation and discussion of each 
Working Group's recommendations. Any supporting documentation for 
this meeting, including the agenda, will be available at http://smrb.od.nih.gov. Sign up for public comment will begin at 
approximately 7:30 a.m. on both September 14 and 15 and will be 
restricted to one sign in per person. In the event that time does 
not allow for all those interested to present oral comments, anyone 
may file written comments using the contact person's address below.
    Place: National Institutes of Health, Building 31, 6th Floor, 
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Time: September 15, 2010, 8 a.m. to 5 p.m.
    Agenda: Continuation of September 14th meeting.
    Place: National Institutes of Health, Building 31, 6th Floor, 
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Lyric Jorgenson, Health Sciences Policy Analyst 
Office of Science Policy, Office of the Director, NIH, National 
Institutes of Health, Building 1, Room 218, MSC 0166, 9000 Rockville 
Pike, Bethesda, MD 20892, [email protected], (301) 496-6837.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    The meeting will also be webcast. The draft meeting agenda and 
other information about the SMRB, including information about access 
to the webcast, will be available at http://smrb.od.nih.gov.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxis, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: August 16, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-20675 Filed 8-19-10; 8:45 am]
BILLING CODE 4140-01-P